<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000350225"><TermName>BB-10901</TermName><TermDefinition><DefinitionText>A substance
          that combines a monoclonal antibody (huN901) with an
          anticancer drug (DM1), and is being studied in the
          treatment of certain cancers, including non-small cell lung
          cancer. Monoclonal antibodies are laboratory-produced
          substances that can locate and bind to cancer
          cells.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>BB-10901</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que combina un
anticuerpo monoclonal (huN901) con un medicamento contra el
cáncer (DM1); está en estudio para tratar ciertos cánceres,
como el cáncer de pulmón de células no pequeñas. Los
anticuerpos monoclonales son sustancias producidas en el
laboratorio que pueden localizar las células cancerosas y
unirse a ellas.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-12-23</DateFirstPublished></GlossaryTerm>
